Follow
Deborah Smith
Deborah Smith
Verified email at york.ac.uk
Title
Cited by
Cited by
Year
The Genome of the Kinetoplastid Parasite, Leishmania major
AC Ivens, CS Peacock, EA Worthey, L Murphy, G Aggarwal, M Berriman, ...
Science 309 (5733), 436-442, 2005
17282005
TriTrypDB: a functional genomic resource for the Trypanosomatidae
M Aslett, C Aurrecoechea, M Berriman, J Brestelli, BP Brunk, M Carrington, ...
Nucleic acids research 38 (suppl_1), D457-D462, 2010
10162010
Comparative genomic analysis of three Leishmania species that cause diverse human disease
CS Peacock, K Seeger, D Harris, L Murphy, JC Ruiz, MA Quail, N Peters, ...
Nature genetics 39 (7), 839-847, 2007
9492007
Immunological modulation and evasion by helminth parasites in human populations
RM Maizels, DAP Bundy, ME Selkirk, DF Smith, RM Anderson
Nature 365 (6449), 797-805, 1993
6851993
Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania
MB Rogers, JD Hilley, NJ Dickens, J Wilkes, PA Bates, DP Depledge, ...
Genome research 21 (12), 2129-2142, 2011
5132011
Toll-Like Receptor 4 Contributes to Efficient Control of Infection with the Protozoan Parasite Leishmania major
P Kropf, MA Freudenberg, M Modolell, HP Price, S Herath, S Antoniazi, ...
Infection and immunity 72 (4), 1920-1928, 2004
3232004
N-myristoyltransferase inhibitors as new leads to treat sleeping sickness
JA Frearson, S Brand, SP McElroy, LAT Cleghorn, O Smid, L Stojanovski, ...
Nature 464 (7289), 728-732, 2010
3152010
Vitellogenesis: a versatile model for hormonal regulation of gene expression
JR Tata, DF Smith
Proceedings of the 1978 Laurentian hormone conference, 47-95, 1979
3081979
GeneDB—an annotation database for pathogens
FJ Logan-Klumpler, N De Silva, U Boehme, MB Rogers, G Velarde, ...
Nucleic acids research 40 (D1), D98-D108, 2012
2792012
Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses
S Stäger, J Alexander, AC Kirby, M Botto, NV Rooijen, DF Smith, ...
Nature medicine 9 (10), 1287-1292, 2003
2562003
Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis
S Stäger, DF Smith, PM Kaye
The journal of immunology 165 (12), 7064-7071, 2000
2442000
Acylation-dependent protein export inLeishmania
DG Russell, PW Denny, S Gokool, MC Field, DF Smith
Journal of Biological Chemistry 275 (15), 11017-11025, 2000
2172000
Myristoyl-CoA: protein N-myristoyltransferase, an essential enzyme and potential drug target in kinetoplastid parasites
HP Price, MR Menon, C Panethymitaki, D Goulding, PG McKean, ...
Journal of Biological Chemistry 278 (9), 7206-7214, 2003
2082003
Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics
MH Gelb, WC Van Voorhis, FS Buckner, K Yokoyama, R Eastman, ...
Molecular and biochemical parasitology 126 (2), 155-163, 2003
1792003
Comparative genomics: from genotype to disease phenotype in the leishmaniases
DF Smith, CS Peacock, AK Cruz
International journal for parasitology 37 (11), 1173-1186, 2007
1702007
Genomic Confirmation of Hybridisation and Recent Inbreeding in a Vector-Isolated Leishmania Population
MB Rogers, T Downing, BA Smith, H Imamura, M Sanders, M Svobodova, ...
PLoS genetics 10 (1), e1004092, 2014
1642014
Dynamic imaging of experimental Leishmania donovani-induced hepatic granulomas detects Kupffer cell-restricted antigen presentation to antigen-specific CD8+ T cells
L Beattie, A Peltan, A Maroof, A Kirby, N Brown, M Coles, DF Smith, ...
PLoS pathogens 6 (3), e1000805, 2010
1482010
Hybridization in parasites: consequences for adaptive evolution, pathogenesis, and public health in a changing world
KC King, RB Stelkens, JP Webster, DF Smith, MA Brockhurst
PLoS pathogens 11 (9), e1005098, 2015
1462015
Proteomic analysis of Leishmania mexicana differentiation
PG Nugent, SA Karsani, R Wait, J Tempero, DF Smith
Molecular and biochemical parasitology 136 (1), 51-62, 2004
1332004
A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH
LCJ Osman M, Mistry A, Keding A, Gabe R, Cook E, Forrester S, Wiggins R, Di ...
PLoS Negl Trop Dis 11 (5), e0005527, 2017
1312017
The system can't perform the operation now. Try again later.
Articles 1–20